指南与共识神经肿瘤

高级别胶质瘤DSC-MRI动态磁敏感对比灌注成像共识推荐

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas.
指南 / 共识 · Neuro Oncol · 2020-01-01

该共识由Jumpstarting脑肿瘤药物开发联盟DSC-MRI标准化小组制定,针对高级别胶质瘤提出与BTIP兼容的DSC-MRI协议。推荐全剂量预负荷加全剂量团注、中间翻转角60°及场强依赖TE,或单剂量时无预负荷、低翻转角30°,以提高脑血容量评估准确性。

要点

  • 全剂量预负荷加全剂量团注、FA 60°、场强依赖TE为最佳准确度方案。
  • 单剂量使用时可选无预负荷、全剂量团注、FA 30°方案。
  • 协议应与BTIP兼容以支持多中心临床试验反应评估。

核心结论

  • 全剂量预负荷加全剂量团注、中间翻转角60°及场强依赖TE(1.5T为40-50ms,3T为20-35ms)对脑血容量估计的准确度和精确度最佳。
  • 若需单剂量对比剂,无预负荷、全剂量团注、低翻转角30°及场强依赖TE表现优异,且减少对比剂用量并消除预负荷剂量和孵育时间变化引入的潜在系统误差。

研究设计与样本

  • 由Jumpstarting脑肿瘤药物开发联盟DSC-MRI标准化小组发布共识推荐,基于文献回顾和委员会证据确定临床DSC-MRI最佳实践。

主要发现

  • DSC-MRI方法学尚未标准化,阻碍其用于多中心试验的反应评估。
  • 共识提供了脉冲序列(梯度回波vs自旋回波)、BTIP兼容对比剂给药(预负荷和团注)、翻转角、回波时间和后处理渗漏校正的循证最佳实践。

关键数值与推荐

  • 全剂量预负荷加全剂量团注时推荐中间翻转角60°,TE随场强变化:1.5T为40-50ms,3T为20-35ms。
  • 单剂量对比剂时推荐无预负荷、全剂量团注、低翻转角30°及场强依赖TE。

临床怎么用

  • 临床进行高级别胶质瘤DSC-MRI时应优先采用本共识推荐的标准化协议,以提高脑血容量评估的准确性和可重复性。
  • 多中心临床试验中应采用与BTIP兼容的DSC-MRI协议,便于反应评估的标准化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite the widespread clinical use of dynamic susceptibility contrast (DSC) MRI, DSC-MRI methodology has not been standardized, hindering its utilization for response assessment in multicenter trials. Recently, the DSC-MRI Standardization Subcommittee of the Jumpstarting Brain Tumor Drug Development Coalition issued an updated consensus DSC-MRI protocol compatible with the standardized brain tumor imaging protocol (BTIP) for high-grade gliomas that is increasingly used in the clinical setting and is the default MRI protocol for the National Clinical Trials Network. After reviewing the basis for controversy over DSC-MRI protocols, this paper provides evidence-based best practices for clinical DSC-MRI as determined by the Committee, including pulse sequence (gradient echo vs spin echo), BTIP-compliant contrast agent dosing (preload and bolus), flip angle (FA), echo time (TE), and post-processing leakage correction. In summary, full-dose preload, full-dose bolus dosing using intermediate (60°) FA and field strength-dependent TE (40-50 ms at 1.5 T, 20-35 ms at 3 T) provides overall best accuracy and precision for cerebral blood volume estimates. When single-dose contrast agent usage is desired, no-preload, full-dose bolus dosing using low FA (30°) and field strength-dependent TE provides excellent performance, with reduced contrast agent usage and elimination of potential systematic errors introduced by variations in preload dose and incubation time.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Boxerman JL, Quarles CC, Hu LS, et al. Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas. Neuro Oncol. 2020. PMID: 32516388. doi:10.1093/neuonc/noaa141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。